Treatment and Survival Disparities in the National Cancer Institute’s Patterns of Care Study (1987–2017)

References

• Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113–2121.
   PubMed Web of Science ®Google Scholar
• Zujewski JA, Harlan LC, Morrell DM, Stevens JL. Ductal carcinoma in situ: trends in treatment over time in the US Breast Cancer Res Treat. 2011;127(1):251–257.
   PubMed Web of Science ®Google Scholar
• Joslyn SA. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J. 2006;12(1):20–27.
   PubMed Web of Science ®Google Scholar
• Flanagan MR, Rendi MH, Gadi VK, Calhoun KE, Gow KW, Javid SH. Adjuvant endocrine therapy in patients with ductal carcinoma in situ: a population-based retrospective analysis from 2005 to 2012 in the National Cancer Data Base. Ann Surg Oncol. 2015;22(10):3264–3272.
   PubMed Web of Science ®Google Scholar
• Harlan LC, Abrams J, Warren J, Clegg L, Stevens J, Ballard-Barbash R. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol. 2002; 20(7):1809–1817.
   PubMed Web of Science ®Google Scholar
• Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R. Community-based use of chemotherapy and hormonal therapy for early stage breast cancer: 1987–2000. J Clin Oncol. 2006;24(6):872–877.
   PubMed Web of Science ®Google Scholar
• Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, Smith BD. Utilization and outcomes of breast brachytherapy in younger women. Int J Radiat Oncol Biol Phys. 2015;93(1):91–101.
   PubMed Web of Science ®Google Scholar
• Mougalian SS, Soulos PR, Killelea BK, et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. 2015;121(15):2544–2552.
   PubMed Web of Science ®Google Scholar
• Tsai HT, Isaacs C, Lynce FC, et al. Initiation of trastuzumab by women younger than 64 years for adjuvant treatment of stage I–III Breast Cancer. J Natl Compr Canc Netw. 2017;15(5):601–607.
   PubMed Web of Science ®Google Scholar
• Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20(5):1192–1202.
   PubMed Web of Science ®Google Scholar
• Cronin D, Harlan LC, Potosky AP, Clegg LX, Stevens JL, Mooney MM. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol. 2008;1010(10):2308–2318.
   Google Scholar
• Murphy C, Harlan LC, Lund JL, Lynch CF, Geiger AM. Patterns of colorectal cancer care in the United States: 1990–2010. J Natl Cancer Inst. 2015;107(10). pii:djv198.
   Google Scholar
• Murphy C, Harlan LC, Warren JL, Geiger AM. Race and insurance differences in the use of adjuvant chemotherapy among patients with stage III colon cancer. J Clin Oncol. 2015;33(23):2530–2536.
   PubMed Web of Science ®Google Scholar
• White A, Liu C, Xia, R, et al. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer. 2008;113(12):3400–3409.
   PubMed Web of Science ®Google Scholar
• Sineshaw HM, Jemal A, Thomas C0R, Mitin T. Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: an analysis from the National Cancer Data Base. Cancer. 2016;122(13):1996–2003.
   PubMed Web of Science ®Google Scholar
• Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003;21(18):3488–3494.
   PubMed Web of Science ®Google Scholar
• Thrall MM, Gray HJ, Symons RG, Weiss NS, Flum DR, Goff BA. Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol. 2011;122(1):100–106.
   PubMed Web of Science ®Google Scholar
• Trimble EL, Harlan LC, Clegg LX, et al. Patterns of care for women with cervical cancer in the United States. Cancer. 2008;113(4):743–749.
   PubMed Web of Science ®Google Scholar
• Robin TP, Amini A, Schefter TE, Behbakht K, Fisher CM. Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer. Gynecol Oncol. 2016;143(2):319–325.
   PubMed Web of Science ®Google Scholar
• Hamilton A, Johnson K, Deapen D, Morrell D, Penson D, Albertson P. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int. 2011;107(4):576–584
   PubMed Web of Science ®Google Scholar
• Amini A, Raben D, Crawford ED, et al. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: a study of the National Cancer Database. Urol Oncol. 2017;35(6):438–446.
   PubMed Web of Science ®Google Scholar
• Gray PJ, Lin CC, Cooperberg MR, Jemal A, Efstathiou JA. Temporal trends and the impact of race, insurance, and socioeconomic status in the management of localized prostate cancer. Eur Urol. 2017;71(5):729–737.
   PubMed Web of Science ®Google Scholar
• Warren JL, Harlan LC, Stevens J, Little R, Abel GA. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States. J Clin Oncol. 2013;31(16):1984–1989.
   PubMed Web of Science ®Google Scholar
• Fiala MA, Wildes TM. Racial disparities in treatment use for multiple myeloma. Cancer. 2017;123(9):1590–1596.
   PubMed Web of Science ®Google Scholar
• Banegas MP, Harlan LC, Mann B, Yabroff R. Renal cell cancer: a shift in approaches for treatment of advanced disease in the United States. J Natl Compr Canc Netw. 2014;12(9):1271–1279.
   PubMed Web of Science ®Google Scholar
• Banegas MP, Harlan LC, Mann B, Yabroff KR. Toward greater adoption of minimally-invasive and nephron-sparing surgical techniques for renal cell cancer in the US. Urol Oncol. 2016;34(10):433.e9–433.e17.
   Web of Science ®Google Scholar
• Shaikh T, Handorf EA, Murphy CT, et al. Contemporary trends in the utilization of radiotherapy in patients with renal cell carcinoma. Urology. 2015;86(6):1165–1173.
   PubMed Web of Science ®Google Scholar
• Kim SP, Gross CP, Meropol N, et al. National treatment trends among older patients with T1-localized renal cell carcinoma. Urol Oncol. 2017;35(3):113.e15–113.e21.
   Web of Science ®Google Scholar
• Plante K, Stewart TM, Wang D, Bratslavsky G, Formica M. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004–2013. Int Urol Nephrol. 2017;49(8):1375–1381.
   PubMed Web of Science ®Google Scholar
• Becker A, Roghmann F, Trinh QD, et al. . Sociodemographic disparities in the treatment of small renal masses. BJU Int. 2013;111(8):E274–E282.
   PubMed Web of Science ®Google Scholar
• Kaniski F, Enewold L, Thomas A, Malik S, Stevens JL, Harlan LC. Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010. Lung Cancer. 2017;103:66–74.
   PubMed Web of Science ®Google Scholar
• Vest MT, Herrin J, Soulos PR, et al. Use of new treatment modalities for non-small cell lung cancer care in the medicare population. Chest. 2013;143(2):429–435.
   PubMed Web of Science ®Google Scholar
• Groth SS, Al-Refaie WB, Zhong W, et al. Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer. Ann Thorac Surg. 2013;95(4):1221–1226.
   PubMed Web of Science ®Google Scholar
• van der Pool AE, Damhuis RA, Ijzermans JN, et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis. 2012;14(1):56–61.
   PubMed Web of Science ®Google Scholar
• Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017.
   PubMed Web of Science ®Google Scholar
• Schabath MB, Thompson ZJ, Gray JE. Temporal trends in demographics and overall survival of non-small cell lung cancer patients at the Moffitt Cancer Center from 1986–2008. Cancer Control. 2014;21(1):51–56.
   PubMed Web of Science ®Google Scholar
• Koshy M, Fedewa SA, Malik R, et al. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small cell lung cancer J Thorac Oncol. 2013;8(7):915–922.
   PubMed Web of Science ®Google Scholar
• Harlan LC, Lynch CF, Ballard-Barbash R, Zeruto C. Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study. Melanoma Res. 2011;21(6):547–554.
   PubMed Web of Science ®Google Scholar
• Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller AC, Halpern AC. Melanoma thickness and survival trends in the United States, 1989–2009. J Natl Cancer Inst. 2015;108(1). pii:djv294.
   Google Scholar
• National Cancer Institute: Overview of the SEER Program [cited 2017 Sep 9]. Available from: http://seer.cancer.gov/about/factsheets/SEER_brochure.pdf.
   Google Scholar
• National Cancer Institute: Cancer MoonshootSM [cited 2017 Nov 30]. Available from: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative.
   Google Scholar
• National Cancer Institute: Community Oncology Research Program (NCORP) [cited 2017 Sep 9]. Available from: https://ncorp.cancer.gov/.
   Google Scholar